Group Effect in Full Replicate Design [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2018-09-12 13:31 (858 d 02:00 ago) – Posting: # 19278
Views: 4,617

Hi GM,

» » For the ABE part (if swR <0.294) like the FDA’s Model II:
  • fixed:
    » » Group, Sequence, Treatment, Period (nested within Group), Group-by-Sequence Interaction
    » »
  • random:
    » » Subject (nested within Group × Sequence)

»
» But as per Progesterone Guidance, Treatment as random term in Average BE.

No way.

» Please see model SAS code from guidance.
»
» MODEL LAUCT = SEQ PER TRT/ DDFM=SATTERTH;
» RANDOM TRT/TYPE=FA0(2) SUB=SUBJ G;

Please make yourself familiar with the syntax of SAS’ PROC MIXED. Terms in the MODEL argument are fixed.

» As per your version, Subject (nested within Group × Sequence) is the random term.
»
» Now am Confused:ponder:,Which is the correct one?

Mine. For the exact setup ask a qualified SAS-coder.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Sunday 15:31 UTC (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5